Anonymous sources
BioInform (blog)
For Vermillion, a Likely Off-Label Play for OVA1 as OVA2 Gains R&D Traction - BioInform (blog)
... where the incidence of ovarian cancer has grown at twice the rate as in the US, according to people familiar with the companies' plans. ...